#week36 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #week36, aggregated by home.social.
-
https://www.europesays.com/dk/101085/ Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026 #BodyWeight #Diabetes #InvestigationalTreatment #JacobMartin #NovoNordisk #Phase3ClinicalTrials #placebo #SubcutaneousDoses #Type2Diabetes #Week36